BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20207826)

  • 1. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
    French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
    Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
    J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.
    Gogali F; Paterakis G; Rassidakis GZ; Kaltsas G; Liakou CI; Gousis P; Neonakis E; Manoussakis MN; Liapi C
    J Clin Endocrinol Metab; 2012 May; 97(5):1474-82. PubMed ID: 22399513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Liu Y; Yun X; Gao M; Yu Y; Li X
    Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.
    Ugolini C; Elisei R; Proietti A; Pelliccioni S; Lupi C; Borrelli N; Viola D; Leocata P; Vitti P; Miccoli P; Toniolo A; Basolo F
    Thyroid; 2014 Feb; 24(2):339-46. PubMed ID: 23915122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.
    French JD; Kotnis GR; Said S; Raeburn CD; McIntyre RC; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E934-43. PubMed ID: 22466343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
    Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
    Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
    Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
    Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
    Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma.
    Lu H; Zhang L; Dai Y; Ruan Y; Cao X; Cai X; Ruan S; Chen Q
    Diagn Pathol; 2020 Feb; 15(1):16. PubMed ID: 32050977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
    Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
    Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
    Pusztaszeri MP; Sadow PM; Faquin WC
    Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
    Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
    Ito M; Bogdanova T; Zurnadzhy L; Saenko V; Rogounovitch T; Mitsutake N; Kondo H; Maeda S; Nakashima M; Tronko M; Yamashita S
    Endocr J; 2014; 61(12):1221-8. PubMed ID: 25242260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.